Purpose-To evaluate the feasibility of using tomotherapy to deliver whole brain radiotherapy (WBRT) with hippocampal avoidance, hypothesized to reduce the risk of memory function decline, and simultaneously integrated boost to brain metastases to improve intra-cranial tumor control.Methods and Materials-Ten patients treated with radiosurgery and WBRT were replanned on tomotherapy using original CT scans and MR-CT fusion defined target and normal structure contours. The individually contoured hippocampus was used as dose-limiting structures (<6Gy); the whole brain dose was prescribed at 32.25 Gy to 95% in 15 fractions and simultaneous boost doses to individual brain metastases were 63 Gy to lesions ≥ 2.0cm in maximum diameter, and 70.8 Gy to lesions < 2.0cm. Plans were generated with a field width (FW) of 2.5cm, and in five patients with FW of 1.0cm. Plans were compared regarding conformation number (CN), prescription isodose to target volume (PITV) ratio, target coverage (TC), homogeneity index (HI), and mean normalized total dose (NTD mean ).Results-A 1.0cm compared with 2.5cm FW significantly improved the dose distribution. Mean CN number improved from 0.55±0.16 to 0.60±0.13. Whole brain homogeneity improved by 32% (p<0.001). NTD mean to the hippocampus were 5.9±1.3 and 5.8±1.9 Gy 2 , for 2.5 and 1.0cm FW, respectively. Mean treatment delivery time for 2.5 and 1.0cm FW plans were 10.2±1.0 and 21.8±1.8 minutes.Conclusions-Composite tomotherapy plans achieved 3 objectives: homogeneous whole brain dose distribution equivalent to conventional WBRT; conformal hippocampal avoidance; radiosurgically-equivalent dose distributions to individual metastases.